Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meier Hsu

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Haematologica|October 15, 2020
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemiaMark B Geyer, Ellen K Ritchie, Arati V Rao, et al.
JAMA Oncology|December 23, 2017
Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer OutcomeTsuyoshi Konishi, Yoshifumi Shimada, Meier Hsu, et al.
JCI Insight|April 3, 2019
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLLMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 29, 2022
Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinomaCaitlin A Harrington, Rebecca A Carr, Meier Hsu, et al.
The American Journal of Surgical Pathology|April 7, 2018
Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic MarkersTsuyoshi Konishi, Yoshifumi Shimada, Lik Hang Lee, et al.
Annals of Surgery|July 5, 2022
Translating Telemedicine to Thoracic Surgical Oncological Care: Performance Analysis and Patient Perceptions During the COVID-19 PandemicCaitlin A Harrington, Meier Hsu, Kay See Tan, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinomaArianna Barbetta, Meier Hsu, Kay See Tan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Annals of Surgery|January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell TumorsRaul Caso, Gregory D Jones, Manjit S Bains, et al.
The Annals of Thoracic Surgery|October 19, 2020
Performance Comparison Between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary ResectionNeel P Chudgar, Shi Yan, Meier Hsu, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Haematologica|October 15, 2020
Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemiaMark B Geyer, Ellen K Ritchie, Arati V Rao, et al.
JAMA Oncology|December 23, 2017
Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer OutcomeTsuyoshi Konishi, Yoshifumi Shimada, Meier Hsu, et al.
JCI Insight|April 3, 2019
Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLLMark B Geyer, Isabelle Rivière, Brigitte Sénéchal, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 29, 2022
Patterns and influence of nodal metastases after neoadjuvant chemoradiation and R0 resection in esophageal adenocarcinomaCaitlin A Harrington, Rebecca A Carr, Meier Hsu, et al.
The American Journal of Surgical Pathology|April 7, 2018
Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic MarkersTsuyoshi Konishi, Yoshifumi Shimada, Lik Hang Lee, et al.
Annals of Surgery|July 5, 2022
Translating Telemedicine to Thoracic Surgical Oncological Care: Performance Analysis and Patient Perceptions During the COVID-19 PandemicCaitlin A Harrington, Meier Hsu, Kay See Tan, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 18, 2018
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinomaArianna Barbetta, Meier Hsu, Kay See Tan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2019
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell TransplantationMichael Scordo, Meier Hsu, Ann A Jakubowski, et al.
Annals of Surgery|January 25, 2020
Outcomes After Multidisciplinary Management of Primary Mediastinal Germ Cell TumorsRaul Caso, Gregory D Jones, Manjit S Bains, et al.
The Annals of Thoracic Surgery|October 19, 2020
Performance Comparison Between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary ResectionNeel P Chudgar, Shi Yan, Meier Hsu, et al.
Pageof 11